Related Experiment Video
Updated: Feb 15, 2026

Single Port Donor Nephrectomy
Published on: March 12, 2011
Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program
Naomi Kawashima1,2, Satoshi Nishiwaki3, Naoko Shimizu4
1Department of Hematology, Japanese Red Cross Nagoya First Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, Aichi, 453-8511, Japan. nkawashima@med.nagoya-u.ac.jp.
Insights
Delays in unrelated donor searches for allogeneic hematopoietic stem cell transplantation (allo-HSCT) impact outcomes. Switching to alternative donors may benefit high-risk patients, showing similar survival rates to those receiving matched unrelated donors.
Area of Science:
- Hematology
- Transplantation Immunology
- Clinical Oncology
Background:
- Unrelated donor stem cell transplantation is crucial for patients lacking matched siblings.
- Donor search delays in allogeneic hematopoietic stem cell transplantation (allo-HSCT) negatively affect patient survival.
- Optimal timing for unrelated donor searches versus alternative donor selection in allo-HSCT is not well-defined.
Purpose of the Study:
- To evaluate the impact of unrelated donor search duration on patient outcomes in allo-HSCT.
- To compare survival rates between patients receiving allo-HSCT from matched unrelated donors, alternative donors, or those who suspended transplantation.
- To determine if alternative donor sources offer a survival benefit for high-risk patients undergoing allo-HSCT.
Main Methods:
- Retrospective analysis of 349 adult patients from the Japan Marrow Donor Program (JMDP) registry.
- Categorization of patients into three groups: allo-HSCT from JMDP donors (Group A), allo-HSCT from alternative sources (Group B), and suspended allo-HSCT (Group C).
- Comparison of 5-year overall survival (OS) rates across the three groups, considering disease risk index (DRI).
Main Results:
- Group A (JMDP donors) had a significantly higher 5-year OS rate (48.6%) compared to Group C (suspended) (38.5%).
- Group B (alternative donors) showed a similar 5-year OS rate (40.9%) to Group A (48.6%), despite including more patients with high or very high DRI.
- The median time to donor identification was 140 days for Group A and 111.5 days for Group B.
Conclusions:
- Waiting for a matched unrelated donor (JMDP) improves survival compared to suspending allo-HSCT.
- Utilizing alternative donor sources can achieve comparable survival outcomes to matched unrelated donors, particularly for high-risk patients.
- These findings support the consideration of alternative donors to mitigate risks associated with prolonged unrelated donor searches in allo-HSCT.
Abstract:
In allogeneic hematopoietic stem cell transplantation (allo-HSCT) from unrelated donors, delays in donor search are adversely associated with patient outcome. However, the optimal duration for either waiting for an unrelated donor or selecting alternative sources remains undetermined. Using data from the Japan Marrow Donor Program (JMDP) registry, we retrospectively analyzed 349 adult patients who had searched for unrelated donors. Two hundred and three patients received allo-HSCT from JMDP donors (Group A) with a median of 140 days required to identify a donor, 60 received allo-HSCT from alternative sources (Group B) after a median of 111.5 days at which point either all donor candidates had failed or the patient achieved a second or subsequent complete remission, and 77 suspended allo-HSCT (Group C) after a median of 310 days. The 5-year overall survival (OS) rate in Group A was superior to that of Group C (48.6 vs 38.5%, P = 0.001). Although Group B included more patients with high or very high disease risk index (DRI) at the time of allo-HSCT compared with Group A, the 5-year OS was not significantly different between Groups A and B (48.6 vs 40.9%, P = 0.07), indicating that switching to alternative donors may benefit patients with high DRI.
Related Concept Videos
Area Computation by the Alternative Coordinate Method
Coordination Compounds and Nomenclature
Coordination Number and Geometry
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Lewis Acids and Bases
A coordinate covalent bond (or dative bond) occurs when one of the atoms in the bond provides both bonding electrons. For example, a coordinate covalent bond occurs when a water molecule combines with a hydrogen ion to form a hydronium ion. A coordinate covalent bond also results when...
Bronsted-Lowry Acids and Bases

